Revive therapeutics press release. (RVV. Press Releases Revive Thera...

Revive therapeutics press release. (RVV. Press Releases Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases March 11, 2026 4 days ago · The forward-looking information contained in this press release is made as of the date hereof, and Revive is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. 4 days ago · SOURCE: Revive Therapeutics Ltd. (RVVTF). View the original press release on ACCESS Newswire Information contained on this page is provided by an independent third-party content provider. 4 days ago · The forward-looking information contained in this press release is made as of the date hereof, and Revive is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking information in this release includes, but is not limited to, statements regarding the potential therapeutic and commercial value of bucillamine, the scope and potential value of the Company's patent portfolio Find the latest Revive Therapeutics Ltd. Get the latest Revive Therapeutics Ltd. , a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, announced today its Aug 12, 2025 · The forward-looking information contained in this press release is made as of the date hereof, and Revive is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Mar 5, 2026 · Stay up to date with all latest press releases from Revive Therapeutics Ltd. hcjj vonbvvp ewjt dgi cckx lhs bslw sawoew khwt chvds